Long-term continuous positive airway pressure (CPAP) outcomes from a sleep service using limited sleep studies and daycase CPAP titration in the management of obstructive sleep apnoea/hypopnoea syndrome

Abstract

Background: Detailed polysomnography (PSG) and overnight continuous positive airway pressure (CPAP) titration as the basis for investigation and treatment of obstructive sleep apnoea/hypopnoea syndrome (OSAHS) incurs high costs from inpatient stays and technician attendance, even when split night studies are employed. Responding to rapidly increasing demand, from 1996 the sleep service at Glasgow Royal Infirmary adopted limited sleep studies and daycase CPAP titration as first line management. Here we describe the outcomes of this service between 1996 and 1999. Methods: Data were collected from prospective records made at follow up by sleep technicians and by casenote review. Results: Results were available for 158 subjects (97.5%) of 162 commenced on CPAP during this period. One hundred and forty-eight (91%) were diagnosed by limited sleep studies and 80 (50%) were diagnosed at home. The median follow up was 23 months (interquartile range (IQR), 13-35). Median use of CPAP in those continuing therapy was 5.3 hours/night (IQR, 3.1 to 6.5) and 77% were still using CPAP at three years. Only initial low CPAP compliance (< 2 hours/night) significantly predicted early CPAP cessation. In those still on CPAP in 1999, the mean drop in Epworth Sleepiness Scale score was 4.6 points (95% confidence intervals, 3.2 to 6.0). Conclusion: These data from the CPAP population at Glasgow Royal Infirmary provide information on longterm outcomes using a diagnostic protocol based on limited sleep studies and daycase CPAP titration.

Keywords

compliance CPAP limited sleep studies obstructive sleep apnoea/hypopnoea syndrome

References

1. Davies RJ , Stradling JR . The epidemiology of sleep apnoea . Thorax 1996; 51: S65-S70 .

2. Whittle AT , Finch SP , Mortimore IL et al. Use of home sleep studies for diagnosis of the sleep apnoea/hypopnoea syndrome . Thorax 1997; 52: 1068-1073 .

3. Bennett LS , Langford BA , Stradling JR et al. Sleep fragmentation indices as predictors of daytime sleepiness and nCPAP response in obstructive sleep apnea . Am J Respir Crit Care Med 1998; 158: 778-786 .

4. Douglas NJ , Thomas S , Jan MA . Clinical value of polysomnography . Lancet 1992; 339: 347-350 .

5. Richards GN , Cistulli PA , Ungar RG et al. Mouth leak with nasal continuous positive airway pressure increases nasal airway resistance . Am J Respir Crit Care Med 1996; 154: 182-186 .

6. McArdle N , Devereux G , Heidarnejad H et al. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome . Am J Resp Crit Care Med 1999; 159: 1108-1114 .

7. Krieger J , Kurtz D , Petiau C et al. Long-term compliance with CPAP therapy in obstructive sleep apnea patients and in snorers . Sleep 1996; 19: S136-S143 .

8. Popescu G , Latham M , Allgar V et al. Continuous positive airway pressure for sleep apnoea/hypopnoea syndrome: usefulness of a 2 week trial to identify factors associated with long term use . Thorax 2001; 56: 727-733 .

9. Rauscher H , Formanek D , Popp W et al. Self-reported vs measured compliance with nasal CPAP for obstructive sleep apnea . Chest 1993; 103: 1675-1680 .

10.

10. Pepin JL , Krieger J , Rodenstein D et al. Effective compliance during the first 3 months of continuous positive airway pressure. A European prospective study of 121 patients . Am J Respir Crit Care Med 1999; 160: 1124-1129 .

11.

11. Reeves-Hoche MK , Meck R , Zwillich CW Nasal CPAP: an objective evaluation of patient compliance . Am J Respir Crit Care Med 1994; 149: 149-154 .

12.

12. Rodenstein D. How to improve compliance to nasal continuous positive airway pressure in sleep apnoea syndrome . Mon Arch Chest Dis 1998; 53: 586-588 .

13.

13. Sin DD , Mayers I , Man GC et al. Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population-based study . Chest 2002; 121: 430-435 .

14.

14. Kribbs NB , Pack Al , Kline LR et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea . Am Rev Respir Dis 1993; 147: 887-895 .

15.

15. Pieters T , Collard P , Aubert G et al. Acceptance and long-term compliance with nCPAP in patients with obstructive sleep apnoea syndrome . Eur Respir J 1996; 9: 939-944 .

16.

16. Lacassagne L , Didier A , Doussau S et al. Results of 248 patients with sleep apnea syndrome treated by continuous positive pressure ventilation between 1990 and 1995. A study of compliance and outcome of the apnea-hypopnea index . Rev Mal Respir 2000; 17: 467-474 .

17.

17. White J , Cates C , Wright J . Continuous positive airways pressure for obstructive sleep apnoea. (Cochrane Review). In: The Cochrane Library, 2004, Chichester: John Wiley and Sons Ltd .

18.

18. Engleman HM , Martin SE , Kingshott RN et al. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome . Thorax 1998; 53: 341-345 .

19.

19. Jenkinson C , Davies RJ , Mullins R et al. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial . Lancet 1999; 353: 2100-2105 .

20.

20. Engleman HM , Asgari-Jirhandeh N , McLeod AL et al. Self-reported use of CPAP and benefits of CPAP therapy: a patient survey . Chest 1996; 109: 1470-1476 .